Prot #LPS16747: A Randomized, Double-blind, Head-to-Head Comparison of Dupilumab Versus Omalizumab in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Comorbid Asthma Patients

Project: Research project

Project Details

StatusActive
Effective start/end date12/8/21 → 12/31/25

Funding

  • Sanofi US Services Inc. (Prot #LPS16747 AMD 1)